Treffer 1 - 13 von 13 für Suche 'Jing Wang (14959256)', Suchdauer: 0,01s Treffer weiter einschränken
  1. 1
    Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

    Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers von Juliana Navarro-Yepes (17079059)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC von Sonia A. Patel (15055688)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC von Sonia A. Patel (15055688)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC von Sonia A. Patel (15055688)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC von Sonia A. Patel (15055688)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC von Sonia A. Patel (15055688)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... von Abdullah A. Osman (15056323)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... von Abdullah A. Osman (15056323)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... von Abdullah A. Osman (15056323)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... von Abdullah A. Osman (15056323)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer

    Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer von Kavya Ramkumar (16474203)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... von Abdullah A. Osman (15056323)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous... von Abdullah A. Osman (15056323)

    Veröffentlicht 2025
    Weitere Verfasser:
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: